Mode
Text Size
Log in / Sign up

Mendelian randomization suggests loneliness causally increases schizophrenia and major depressive disorder risk.

Mendelian randomization suggests loneliness causally increases schizophrenia and major depressive di…
Photo by Brett Jordan / Unsplash
Key Takeaway
Consider loneliness as a potential causal risk factor for schizophrenia and major depressive disorder, with inflammatory pathways involved.

This Mendelian randomization study examined the causal link between loneliness and severe mental illness, specifically schizophrenia, major depressive disorder, and bipolar disorder. The analysis utilized genetic instruments to assess whether loneliness acts as a risk factor for these conditions. No specific population, sample size, or setting details were reported in the available data.

For schizophrenia and major depressive disorder, the study found a causal effect of loneliness consistent with an increased risk. Conversely, no significant effects were identified for bipolar disorder. The analysis also explored inflammatory cytokine pathways, including IL-1RA, IL-6R, and TNF-R1, which partially mediated the causal effects of loneliness on schizophrenia and major depressive disorder.

Evidence of reverse causation was suggested between schizophrenia and loneliness, indicating a potential bidirectional relationship. Safety and tolerability data were not reported, as this study design does not typically evaluate adverse events from an intervention. Key limitations include the fact that the causal relationship with severe mental illness and the specific role of inflammatory signaling remain unclear based on this evidence alone.

The practice relevance lies in highlighting potential opportunities for prevention and targeted intervention through inflammation and social pathways. Clinicians should interpret these results as suggestive of a causal link rather than definitive proof, given the inherent limitations of observational-style genetic analyses and the lack of reported certainty metrics.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
BackgroundLoneliness is a psychosocial stressor associated with elevated risk of severe mental illness (SMI), including major depressive disorder (MDD), schizophrenia (SCZ), and bipolar disorder (BD). Loneliness is theorized to become biologically embedded via inflammation-related mechanisms, yet its causal relationship with SMI and the role of inflammatory signaling remain unclear. AimsTo investigate whether loneliness causally influences SMI risk and whether inflammatory cytokines mediate this relationship. MethodWe applied univariable Mendelian randomization (MR) to estimate the causal effect of loneliness on SMI and multivariable MR (MVMR) to assess mediation by inflammatory signaling. We integrated genome-wide association study (GWAS) summary statistics for loneliness and SMI with genetic instruments for inflammatory cytokines. MVMR models estimated the direct effect of loneliness after accounting for inflammatory signaling using eQTL and pQTLs for interleukin-1 receptor antagonist (IL-1RA), interleukin-6 (IL-6), IL-6 receptor (IL-6R), tumor necrosis factor alpha (TNF-), and TNF receptors (TNF-R1/2). Bidirectional MR examined potential reverse causal pathways between inflammation, SMI, and loneliness. ResultsMR provided evidence consistent with a causal effect of loneliness on SCZ and MDD. Results were also consistent with inflammatory cytokine pathways for IL-1RA, IL-6R, and TNF-R1, partially mediating the loneliness-SCZ and loneliness-MDD causal effect. No significant effects were identified for BD in UVMR or MVMR models. Bidirectional MR suggested evidence of reverse causation between SCZ and loneliness. ConclusionsThe findings support a causal risk-increasing effect of loneliness on SCZ and MDD, partially mediated by systemic inflammatory signaling, implicating pathways as a plausible mechanistic link between psychosocial stress and mental illness risk and highlighting potential opportunities for prevention and targeted intervention through inflammation and social pathways.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.